Key Gene Panel Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The competitive landscape of the market is rapidly evolving as established key players, healthcare giants, and new entrants are investing in including novel medicines. Key players in the market are focused on developing new technologies and products that cater to the stringent regulatory norms and consumer demand. These key players are adopting several strategies, such as mergers and acquisitions, joint ventures, partnerships, and novel product launches, to enhance their product base and strengthen their market position.
Top 20 Global Manufacturers in the Gene Panel Market:
|
Company Name |
Country of Origin |
2024 Market Share |
|
Illumina, Inc. |
USA |
16.1% |
|
Thermo Fisher Scientific |
USA |
12.5% |
|
Roche Diagnostics |
Switzerland |
9.9% |
|
Qiagen N.V. |
Germany |
8.2% |
|
BGI Genomics |
China |
6.8% |
|
Invitae Corporation |
USA |
xx% |
|
Myriad Genetics |
USA |
xx% |
|
Agilent Technologies |
USA |
xx% |
|
Foundation Medicine (Roche) |
USA |
xx% |
|
Bio-Rad Laboratories |
USA |
xx% |
|
Genetron Health |
China |
xx% |
|
Macrogen Inc. |
South Korea |
xx% |
|
CENTOGENE N.V. |
Germany |
xx% |
|
GENEWIZ (Azenta Life Sci.) |
USA |
xx% |
|
Eurofins Scientific |
France |
xx% |
|
DNA Nexus |
USA |
xx% |
|
Genesis Healthcare |
Japan |
xx% |
|
Genetic Technologies Ltd. |
Australia |
xx% |
|
MedGenome |
India |
xx% |
|
Neoscience Sdn Bhd |
Malaysia |
xx% |
Below are the areas covered for each company in the market:
